Strong Q4 Financial Outperformance
Adjusted EPS of $0.27 in Q4 2025 vs $0.16 in Q4 2024, up 69%; normalized FFO per share $0.52 vs $0.39, up 33%; adjusted EBITDA $92.5M vs $74.2M, up 25%. Adjusted EPS beat analyst estimates by $0.09 and adjusted EBITDA beat by $9M.
Federal Revenue Surge Driven by ICE
Federal partners comprised 57% of Q4 revenue; federal revenue increased 49% YoY. ICE revenue rose $124.4M or 103.4% YoY, fueling the majority of the top-line improvement.
Occupancy and Population Growth
Average daily population increased to 56,380 in Q4 2025 vs 50,202 in Q4 2024 (+12.3%); total Safety & Community occupancy at 78.1%, up 2.6 percentage points year-over-year.
Reactivations and Near-Term Revenue Run-Rate
Three of four previously idle facilities are receiving populations; the three new H2 2025 contract awards (excluding Midwest Regional) are expected to generate ~ $260M of annual revenue once normalized. Company expects a 2026 annual revenue run-rate of ~ $2.5B and an EBITDA run-rate of ~ $450M (almost $100M YoY improvement) once stabilizations complete.
Balance Sheet Flexibility and Liquidity
Expanded revolving credit facility from $275M to $575M; total bank commitments $700M (including $125M term loan). Cash on hand $97.9M and incremental borrowing capacity $311.4M for total liquidity of ~$409.3M. Net debt-to-adjusted EBITDA of 2.8x (TTM).
Aggressive Share Repurchase Program
Repurchased 5.3M shares in Q4 for $97.3M; YTD repurchases 11.2M shares for $218.4M. Since 2022 repurchases total 25.7M shares for $399.5M ($15.52/share). Board authorization increased, with $300.5M remaining under authorization and cumulative authorization up to $700M.
2026 Guidance and Cash Flow Outlook
2026 guidance: diluted EPS $1.49–$1.59; FFO per share $2.54–$2.64; EBITDA $437M–$445M. AFFO forecast $245M–$259.3M; maintenance CapEx $60M–$70M, activation-related CapEx $35M–$40M. Guidance implies midpoint EBITDA and EPS growth of approximately 21% and 40% respectively year-over-year (at midpoint).
Operational Quality and Accreditations
Multiple facilities achieved exemplary outcomes at ACA reaccreditation hearings (three correctional facilities and three residential reentry facilities with near-perfect scores). Dilley facility re-contracted through 2030 with federal monitoring and performance standards.